# MiMedx Group (MDXG) — Analyst Forecast

MDXG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mdxg/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 27, 2026 | Craig-Hallum | Maintained | Buy | $8.00 |
| Aug 17, 2026 | Cantor Fitzgerald | Maintained | Overweight | $8.00 |
| Apr 30, 2026 | Citizens | Maintained | Market Outperform | $6.00 |
| Apr 20, 2026 | Citizens | Maintained | Market Outperform | $7.00 |
| Apr 17, 2026 | Craig-Hallum | Maintained | Buy | $7.00 |
| Feb 23, 2026 | Citizens | Initiated Coverage | Market Outperform | $10.00 |
| Feb 17, 2026 | Cantor Fitzgerald | Maintained | Overweight | $8.00 |
| Jan 20, 2026 | Lake Street | Maintained | Buy | $10.00 |
| Dec 17, 2025 | Mizuho | Maintained | Outperform | $10.00 |
| Jul 31, 2025 | Cantor Fitzgerald | Maintained | Overweight | $12.00 |
| Jul 15, 2025 | Cantor Fitzgerald | Maintained | Overweight | $11.00 |
| Feb 27, 2025 | Cantor Fitzgerald | Maintained | Overweight | $13.00 |
| Aug 1, 2024 | Craig-Hallum | Maintained | Buy | $12.00 |
| Aug 1, 2024 | Cantor Fitzgerald | Maintained | Overweight | $11.00 |
| Jul 2, 2024 | Cantor Fitzgerald | Initiated Coverage | Overweight | $11.00 |
| May 1, 2024 | HC Wainwright & Co. | Maintained | Buy | $11.00 |
| Mar 1, 2024 | Mizuho | Maintained | Buy | $14.00 |
| Oct 31, 2023 | Mizuho | Maintained | Buy | $12.00 |
| Oct 27, 2023 | Craig-Hallum | Initiated Coverage | Buy | $12.00 |
| Aug 2, 2023 | Mizuho | Maintained | Buy | $12.00 |

## Frequently Asked Questions

### Is MDXG a buy, sell, or hold?

Analysts covering MiMedx Group currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on MDXG?

On Aug 27, 2026, Craig-Hallum maintained MiMedx Group at Buy with a price target of $8.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).